David Mehalick - Jan 5, 2024 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
CEO and President, Director, 10%+ Owner
Signature
/s/ David Mehalick
Stock symbol
COEP
Transactions as of
Jan 5, 2024
Transactions value $
$16,747
Form type
4
Date filed
1/9/2024, 05:30 PM
Previous filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Purchase $3.48K +5.05K +0.18% $0.69 2.76M Jan 5, 2024 Direct F1
transaction COEP Common Stock Purchase $4.02K +6K +0.22% $0.67 2.77M Jan 8, 2024 Direct F1
transaction COEP Common Stock Purchase $9.24K +14K +0.51% $0.66 2.78M Jan 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.